{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:26:57Z","timestamp":1784773617925,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbacli.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T06:27:59Z","timestamp":1466058479000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?"],"prefix":"10.1016","volume":"6","author":[{"given":"Nandini","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Gongora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbacli.2016.06.001_bb0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/imj.12532","article-title":"Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship","volume":"44","author":"Nolan","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2014.05.002","article-title":"Cardio-oncology: role of echocardiography","volume":"57","author":"Villarraga","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12350-013-9707-1","article-title":"Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively","volume":"20","author":"Schwartz","year":"2013","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0025","first-page":"59","article-title":"Chemotherapy-induced cardiotoxicity","volume":"8","author":"Florescu","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-2828(87)80392-9","article-title":"Subcellular effects of adriamycin in the heart a concise review","volume":"19","author":"Singal","year":"1987","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/mol.63.4.849","article-title":"Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells inhibition of the ferritin iron mobilization pathway","volume":"63","author":"Kwok","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0045","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy incidence pathogenesis diagnosis and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0050","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibitors","volume":"7","author":"Force","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0060","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000236935","article-title":"Human heart mast cells in anaphylaxis and cardiovascular disease","volume":"107","author":"Marone","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0070","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.154.6.2855","article-title":"Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization","volume":"154","author":"Patella","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.farma.2011.02.004","article-title":"Review of hypersensitivity reactions to antineoplastic agents","volume":"36","author":"Cortijo-Cascajares","year":"2012","journal-title":"Farm. Hosp."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0080","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.3747\/co.21.1966","article-title":"Management of hypersensitivity to platinum- and taxane-based chemotherapy: review and clinical recommendations","volume":"21","author":"Boulanger","year":"2014","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340311799960681","article-title":"Management of chemotherapy induced cardiomyopathy","volume":"7","author":"Saidi","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"issue":"Suppl. 7","key":"10.1016\/j.bbacli.2016.06.001_bb0090","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0095","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy diagnosis pathogenesis and management","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0105","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"Negishi","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/annonc\/mdf170","article-title":"Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy","volume":"13","author":"Cardinale","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2796.2002.00951.x","article-title":"Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction","volume":"251","author":"Nousiainen","year":"2002","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0125","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","author":"van Dalen","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients","volume":"13","author":"Jensen","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0135","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.healun.2004.12.108","article-title":"Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure","volume":"24","author":"Tallaj","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.110.082784","article-title":"Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity","volume":"52","author":"de Geus-Oei","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(09)70042-7","article-title":"Cardiovascular toxicity caused by cancer treatment: strategies for early detection","volume":"10","author":"Altena","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0150","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","article-title":"Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging","volume":"28","author":"Walker","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0155","first-page":"B52","article-title":"Can early changes in 2-dimensional speckle tracking echocardiography predict a future decrease in left ventricular ejection fraction in lymphoma patients undergoing anthracycline chemotherapy?","volume":"26","author":"Xu","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0160","doi-asserted-by":"crossref","first-page":"A199","DOI":"10.1016\/S0735-1097(14)60829-9","article-title":"Two dimensional speckle tracking echocardiography predicts preclinical cardiotoxicity in breast cancer patients","volume":"63","author":"Sandhu","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","article-title":"Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction","volume":"25","author":"Poterucha","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.echo.2015.02.001","article-title":"Time trends of left ventricular ejection fraction and myocardial deformation indices in a cohort of women with breast cancer treated with anthracyclines, taxanes, and trastuzumab","volume":"28","author":"Tan","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/echo.13168","article-title":"Left ventricular global longitudinal strain in HER-2+ breast cancer patients treated with anthracyclines and trastuzumab who develop cardiotoxicity is associated with subsequent recovery of left ventricular ejection fraction","volume":"33","author":"Fei","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0185","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jcmg.2014.06.007","article-title":"Noninvasive imaging of cardiovascular injury related to the treatment of cancer","volume":"7","author":"Kongbundansuk","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12350-012-9512-2","article-title":"Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs","volume":"19","author":"Jiji","year":"2012","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0195","doi-asserted-by":"crossref","first-page":"P53","DOI":"10.1186\/1532-429X-15-S1-P53","article-title":"T2 mapping in different cardiomyopathies: first clinical experience","volume":"15","author":"Bonner","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","article-title":"Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study","volume":"141","author":"Wassmuth","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-15-48","article-title":"Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling","volume":"15","author":"Tham","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0210","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2214\/AJR.07.2822","article-title":"Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue","volume":"190","author":"Wiginton","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0220","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0225","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00395.2008","article-title":"The impact of endurance exercise training on left ventricular systolic mechanics","volume":"295","author":"Baggish","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0230","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2009.04.061","article-title":"Global 2-dimensional strain as a new prognosticator in patients with heart failure","volume":"54","author":"Cho","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0235","first-page":"5383","article-title":"Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy","author":"Bertini","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/echo.12142","article-title":"Independent role of left ventricular global longitudinal strain in predicting prognosis of chronic heart failure patients","author":"Iacoviello","year":"2013","journal-title":"Echocardiography"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0245","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","article-title":"Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring","volume":"2","author":"Stanton","year":"2009","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/1741826711398179","article-title":"Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on peripheral circulation","volume":"18","author":"Lekakis","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0255","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","article-title":"Biochemical markers for prediction of chemotherapy-induced cardiotoxicity systematic review of the literature and recommendations for use","volume":"130","author":"Dolci","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1373\/clinchem.2015.241232","article-title":"Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab","volume":"61","author":"Putt","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0265","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","article-title":"Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","volume":"25","author":"Courneya","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0270","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/jnci\/djt297","article-title":"Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial","volume":"105","author":"Courneya","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0275","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1249\/MSS.0000000000000297","article-title":"Effects of exercise during adjuvant chemotherapy on breast cancer outcomes","volume":"46","author":"Courneya","year":"2014","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/0284186X.2013.781673","article-title":"Safety and efficacy of aerobic training inoperable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial","volume":"53","author":"Hornsby","year":"2014","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0285","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002820-200603000-00013","article-title":"Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy","volume":"29","author":"Kim","year":"2006","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0290","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00006199-198911000-00007","article-title":"Effects of aerobic interval training on cancer patients' functional capacity","volume":"38","author":"MacVicar","year":"1989","journal-title":"Nurs. Res."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0295","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1158\/1078-0432.CCR-09-0628","article-title":"Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training","volume":"15","author":"Haykowsky","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0300","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2001.19.3.657","article-title":"Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial","volume":"19","author":"Segal","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0305","first-page":"319","article-title":"Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: a pilot study","volume":"49","author":"Vincent","year":"2013","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0310","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1249\/01.mss.0000175857.84936.1a","article-title":"Exercise and lymphocyte activation following chemotherapy for breast cancer","volume":"37","author":"Hutnick","year":"2005","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0315","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2003.04.093","article-title":"Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes","volume":"21","author":"Courneya","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0320","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2006.09.5083","article-title":"Randomized trial of exercise therapy in women treated for breast cancer","volume":"25","author":"Daley","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0325","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1200\/JCO.2005.03.080","article-title":"Home-based physical activity intervention for breast cancer patients","volume":"23","author":"Pinto","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0330","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/cncr.22862","article-title":"Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment","volume":"110","author":"Schneider","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0335","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.109.856310","article-title":"Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure","volume":"120","author":"Ky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejheart.2006.05.010","article-title":"Serum HER2 levels are increased in patients with chronic heart failure","volume":"9","author":"Perik","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0350","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80043-4","article-title":"Stress pathways and heart failure","volume":"98","author":"Chien","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0355","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm0502-459","article-title":"ErbB2 is essential in the prevention of dilated cardiomyopathy","volume":"8","author":"Crone","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0360","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2007.02.055","article-title":"A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed","volume":"49","author":"Haykowsky","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1634\/theoncologist.2012-0226","article-title":"The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics","volume":"18","author":"Scott","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1534735408330717","article-title":"Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise","volume":"8","author":"Wonders","year":"2009","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0375","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/JES.0b013e3181aa65fc","article-title":"High-intensity interval training to maximize cardiac benefits of exercise training?","volume":"37","author":"Wisl\u00f8ff","year":"2009","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0385","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1161\/CIRCULATIONAHA.106.675041","article-title":"Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study","volume":"115","author":"Wisl\u00f8ff","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0390","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1249\/MSS.0b013e318163744a","article-title":"Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction","volume":"40","author":"Hydock","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0395","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-013-2808-3","article-title":"The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer","volume":"143","author":"Sturgeon","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0400","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCULATIONAHA.111.021774","article-title":"Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms","volume":"124","author":"Scott","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/CS20100254","article-title":"Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats","volume":"120","author":"Ascensao","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbacli.2016.06.001_bb0410","doi-asserted-by":"crossref","first-page":"H722","DOI":"10.1152\/ajpheart.01249.2004","article-title":"Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis","volume":"289","author":"Ascens\u00e3o","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0415","doi-asserted-by":"crossref","first-page":"H1515","DOI":"10.1152\/ajpheart.00585.2010","article-title":"Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72","volume":"299","author":"Kavazis","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0420","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijcard.2004.11.004","article-title":"Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice","volume":"100","author":"Ascens\u00e3o","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0425","doi-asserted-by":"crossref","first-page":"R424","DOI":"10.1152\/ajpregu.00636.2004","article-title":"Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart","volume":"289","author":"Chicco","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbacli.2016.06.001_bb0430","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1534735408322848","article-title":"Acute exercise protects against doxorubicin cardiotoxicity","volume":"7","author":"Wonders","year":"2008","journal-title":"Integr. Cancer Ther."}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T22:29:55Z","timestamp":1692397795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214647416300289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":86,"alternative-id":["S2214647416300289"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.06.001","relation":{},"ISSN":["2214-6474"],"issn-type":[{"value":"2214-6474","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}